Changes in post-treatment cardiac PET avidity predict overall survival in lung cancer patients treated with chemoradiation: Secondary analysis of the ACRIN 6668/RTOG 0235 clinical trial

The purpose of this work was to use data from a large co-operative group trial to evaluate whether metabolic FDG-PET changes in the heart for lung cancer patients can predict for clinical outcomes. The study found that cardiac SUV changes following definitive chemoradiation are significantly (HR 0.8...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Ryan, Santangelo, Tess, Forghani-Arani, Farnoush, Rusthoven, Chad, Chen, Yingxuan, Castillo, Edward, Castillo, Richard, Guerrero, Thomas, Vinogradskiy, Yevgeniy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660739/
https://www.ncbi.nlm.nih.gov/pubmed/35413391
http://dx.doi.org/10.1016/j.radonc.2022.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660739/
https://www.ncbi.nlm.nih.gov/pubmed/35413391
http://dx.doi.org/10.1016/j.radonc.2022.04.003

Ejemplares similares